PSA levels appear to be more predictive of three year risk in African-American men compared with Caucasian men with a family history of , according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.Cancer Prevention Research...
The researchers found that PSA levels are lower in men with prostate cancer than those who have undergone operations but did not have cancer. They also insisted that the PSA is produced by benign prostatic hype...
Prevalence of Prostate Cancer Among Men with Normal PSA LevelsProstate CancerNew England Journal of Medicine
PSA testing has revolutionized our ability to diagnose, treat, and follow-up patients. The present study evaluated PSA levels in recently diagnosed prostate cancer cases in screening. PSA was estimated by enzyme immunochemical assay in 128 patients. The study concluded that early diagnosis of ...
When Should I Have My PSA Levels Tested? The first thing to do is to talk to your doctor about the pros and cons of prostate cancer screening before you decide whether to be tested. Don’t get tested until you have that talk. Opinions differ about when you should do that. ...
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.doi:10.1371/journal.pone.0134134To reduce the number of unnecessary biopsies in patients with benign prostatic disease, however, without missing significant PCa the present study ...
When Should I Have My PSA Levels Tested? The first thing to do is to talk to your doctor about the pros and cons of prostate cancer screening before you decide whether to be tested. Don’t get tested until you have that talk. Opinions differ about when you should do that. ...
Beyond lowering cholesterol, statin medications have been found to have numerous other health benefits, including lowering a healthy man's risk of developing advanced prostate cancer, as well as lowering his prostate-specific antigen (PSA) levels.
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival. ...
PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10ng/ml This study intended to evaluate the diagnostic accuracy of the prostate imaging reporting and data system (PI-RADS) and prostate-specific antigen density (... J Wen...